http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Harris Alexopoulos (검색결과 1 건)
- 무료
- 기관 내 무료
- 유료
-
Achilleas Attilakos,Lambros Fotis,Argirios Dinopoulos,Harris Alexopoulos,Aikaterini Vasileiou Theofilopoulou,Athanasios George Tzioufas,Sotiria Mastroyianni,Maria Karalexi,Anastasia Garoufi 대한신경과학회 2020 Journal of Clinical Neurology Vol.16 No.1
Background and Purpose The high prevalence of antiphospholipid antibodies (aPL) and antinuclear antibodies (ANA) in patients with epilepsy may be associated with either the disease itself or the antiepileptic treatment. The purpose of this prospective study was to determine the prevalence of aPL and ANA in children with idiopathic epilepsy before and during treatment with antiepileptic drugs. Methods aPL, including both anticardiolipin and anti-β2-glycoprotein I antibodies, and ANA statuses were determined in 40 healthy children, 30 children treated with sodium valproate (VPA) monotherapy, and 20 children treated with carbamazepine (CBZ) monotherapy before and at 6, 12, and 24 months after treatment initiation. Results Fifteen children (50%) in the VPA-treated group and 7 (35%) in the CBZ-treated group showed positivity for aPL before treatment initiation, compared with only 4 of the 40 controls. Nine children (30%) in the VPA-treated group and 4 (20%) in the CBZ-treated group showed positivity for ANA before treatment initiation, compared with only 2 of the 40 controls. The subgroup analysis found nonsignificant associations at the different time points regarding the positivity of all of the autoantibodies. Only patients treated with VPA had a significantly decreased risk of aPL positivity after 6 months of treatment. Conclusions The increased prevalence of autoantibodies in children with idiopathic epilepsy is strongly associated with the disease itself.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
